Nasdaq: CHRS
Coherus Oncology insiders
The officers, directors and 10% owners of Coherus Oncology, Inc. who hold the most stock, valued at the live CHRS price.
$0.39
CHRS today −$23K (−5.56%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their CHRS stock
- $23K
- Market value
- $63.5M
- Held by ranked insiders
- <0.1%
Insiders by value of CHRS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Ali J. Satvat | Director | 30,000 | $12K | <0.1% | 7082nd |
| 2 | Rita A. Karachun | Director | 30,000 | $12K | <0.1% | 12653rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Coherus Oncology; see each profile for the filing.